We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

29 hedge funds and large institutions have $6M invested in Microbot Medical in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

16% more funds holding

Funds holding: 25 → 29 (+4)

0.56% less ownership

Funds ownership: 11.18% → 10.62% (-0.56%)

11% less capital invested

Capital invested by funds: $6.77M → $6M (-$771K)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
29
Holders Change
+4
Holders Change %
+16%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$403K
2
Renaissance Technologies
Renaissance Technologies
New York
+$303K
3
State Street
State Street
Massachusetts
+$260K
4
Morgan Stanley
Morgan Stanley
New York
+$11.3K
5
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$7.55K

Top Sellers

Rank Fund Capital Flow
1
XI
XXEC Inc
Oklahoma
-$788K
2
BlackRock
BlackRock
New York
-$420K
3
Millennium Management
Millennium Management
New York
-$96K
4
Citadel Advisors
Citadel Advisors
Florida
-$47.6K
5
Barclays
Barclays
United Kingdom
-$21.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIS
26
Sound Income Strategies
Florida
– -$9 -1 Closed
AW
27
Alaethes Wealth
Nevada
– +$8 +1 New
PCFFS
28
Pacific Center for Financial Services
California
– +$8 +1 New
1
2

MBOT Hedge Fund Activity: Q2 2021 in Review

29 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2021, worth a combined $6M — down 11% from $6.77M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MBOT positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $403K. The largest seller was XXEC Inc, exiting entirely with an estimated $788K sold.

  • 29 institutional investors held Microbot Medical (MBOT) as of Q2 2021, up from 25 in Q1 2021.
  • Funds reported $6M of Microbot Medical stock for Q2 2021, down 11% quarter-over-quarter.
  • 7 funds opened new Microbot Medical positions in Q2 2021 and 3 closed out, a net change of +4 holders.
  • The largest Microbot Medical buyer in Q2 2021 was Dimensional Fund Advisors, an estimated $403K added.
  • The largest Microbot Medical seller in Q2 2021 was XXEC Inc, an estimated $788K sold.

Based on aggregated 13F filings for Q2 2021.